Evidence map›Paper›PMID 34812413›Full record

ArticleScientific African2021

Genetic algorithm with cross-validation-based epidemic model and application to the early diffusion of COVID-19 in Algeria.

M T Rouabah, A Tounsi, N E Belaloui

Abstract read
In one paragraph

Article in Scientific African, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

M T RouabahLaboratoire de Physique Mathématique et Subatomique Frères Mentouri University Constantine - 1, Ain El Bey Road, Constantine 25017, Algeria.
A TounsiLaboratoire de Physique Mathématique et Subatomique Frères Mentouri University Constantine - 1, Ain El Bey Road, Constantine 25017, Algeria.
N E BelalouiLaboratoire de Physique Mathématique et Subatomique Frères Mentouri University Constantine - 1, Ain El Bey Road, Constantine 25017, Algeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A dynamical epidemic model optimized using a genetic algorithm and a cross-validation method to overcome the overfitting problem is proposed. The cross-validation procedure is applied so that available data are split into a training subset used to fit the algorithm's parameters, and a smaller subset used for validation. This process is tested on Italy, Spain, Germany, and South Korea cases before being applied to Algeria. Interestingly, our study reveals an inverse relationship between the size of the training sample and the number of generations required in the genetic algorithm. Moreover, the enhanced compartmental model presented in this work has proven to be a reliable tool to estimate key epidemic parameters and the non-measurable asymptomatic infected portion of the susceptible population to establish a realistic nowcast and forecast of the epidemic's evolution. The model is employed to study the COVID-19 outbreak dynamics in Algeria between February 25th, 2020, and May 24th, 2020. The basic reproduction number and effective reproduction number on May 24th, after three months of the outbreak, are estimated to be 3.78 (95% CI 3.033-4.53) and 0.651 (95% CI 0.539-0.761), respectively. Disease incidence, CFR, and IFR are also calculated. Numerical programs developed for this study are made publicly accessible for reproduction and further use.

Indexed as

AlgeriaCOVID-19Cross-validationDisease spread modelingGenetic algorithm

Identifiers

PMID34812413
PMCPMC8600802

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.